🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT06354010
Recruiting Observational

Cross-sectional and Prospective Study to Characterize Early-onset Presbycusis

NCT06354010 · tracked via the Priya Life Science USA tracker
Sponsor
Sensorion
Phase
Observational
Started
2024-06-14
Last updated
2026-05-08

Condition(s) studied

Sensorineural Hearing Loss, Bilateral

Investigational drug(s) / intervention(s)

GenotypingAudiological assessments

Genotyping: Genotyping to determine if patients present mutations to the gene GJB2.

Audiological assessments: Audiological assessments

Study summary

The purpose of this study is to characterize and assess the evolution of hearing impairment of patients with adulthood-onset bilateral sensorineural hearing loss carrying mutations on GJB2 gene.

Eligibility

Sex
ALL
Min age
30 Years
Max age
55 Years
Healthy volunteers
No
Inclusion Criteria: 1. Female or Male patients ≥30 and ≤55 years old 2. Bilateral hearing loss first noticed after the age of 16 years old 3. Documented genotyping results showing mutations in GJB2 gene. Exclusion Criteria: 1. Deafness with a known, non-genetic cause 2. To the opinion of the investigator, unable and/or unwilling to comply with all the protocol requirements and/or study procedures

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
The University of South Florida Board of Trustees Tampa Florida Recruiting
CHU Gui de Chauliac Montpellier France Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06354010 on ClinicalTrials.gov ↗ ← All trials in the USA